Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2007
Activity-based costing evaluation of [18F]-fludeoxyglucose productionBruno Krug, Annie Van Zanten, Anne-Sophie Pirson, et al.
Health Policy (Amsterdam, Netherlands)|May 19, 2009
Activity-based costing evaluation of a [(18)F]-fludeoxyglucose positron emission tomography studyBruno Krug, Annie Van Zanten, Anne-Sophie Pirson, et al.
Clinical Nuclear Medicine|January 22, 2004
FDG PET utility in paraneoplastic sweet syndromeBruno Krug, Anne Sonet, Anne-Sophie Pirson, et al.
Radiology|November 18, 2008
Role of PET in the initial staging of cutaneous malignant melanoma: systematic reviewBruno Krug, Ralph Crott, Max Lonneux, et al.
Therapeutic Advances in Medical Oncology|February 6, 2018
Refractory thyroid carcinoma: which systemic treatment to use?Laurence Faugeras, Anne-Sophie Pirson, Julian Donckier, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2010
Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanomaBruno Krug, Ralph Crott, Isabelle Roch, et al.
Clinical Nuclear Medicine|August 2, 2007
An uncommon case of septic cortical osteitisChristian Picard, Bruno Krug, Yves Boutsen, et al.
Head & Neck|February 29, 2024
Reliability and outcomes of lymph nodes biopsy in cT1-cT2 N0 supraglottic laryngeal squamous cell carcinomaMaryline Hoste, Sébastien Van der Vorst, Georges Lawson, et al.
Pageof 1